• Many patients do not present to GPs, at least initially.^2,4 73% of people from a black, Asian or ethnic minority background waited over a year from first experiencing symptoms before going to the GP²
• Many patients have faced stigma or trivialisation of their condition, which can be a barrier to seeking help^2,3
• Some patients face a long delay to accurate diagnosis. 29% of people (41% in black, Asian and ethnic minority groups) with migraine in the UK required five or more consultations before diagnosis²

Including the effects on functional disability, lifestyle and work/ education, as well as the frequency and severity of attacks and most bothersome symptom(s)

Is it pain freedom? Faster recovery? The ability to continue with activities during the migraine attack?

Not just based on response and side effects, but also:
Do they have a high pill burden? Is nausea making oral tablets hard to take? Are they confident with self-injection?

In a meta-analysis of 21 studies, the following treatment preferences were identified for patients with migraine:¹³

Acute treatment

• Patients preferred treatments with a fast onset of action, a long duration of action and few adverse events
• Important outcomes included rapid and complete pain relief, ability to return to normal activities, and no recurrence of migraine

Preventive treatment

• Efficacy (reduction in frequency of migraine) was most important to patients, both in preference to avoiding adverse events and if it would require taking more than one therapy
• Patients in general preferred fewer adverse events, less frequent dosing regimens and greater convenience

• correct identification and diagnosis of headache disorders
• making appropriate referrals to secondary care
• supporting patients to self-manage their condition after diagnosis
• long-term management of patients in primary or community care